GSE159550
m6A independent genome-wide METTL3 and METTL14 redistribution drives senescence-associated secretory phenotype [carRNA-m6A-seq]
Methyltransferase-like 3 (METTL3) and 14 (METTL14) are core subunits of the methyltransferase complex (MTC) that catalyzes mRNA N6-methyladenosine (m6A) modification.  Despite the expanding list of m6A-dependent function of the MTC, m6A independent function of the METTL3 and METTL14 complex remains poorly understood.  Here we show that genome-wide redistribution of METTL3 and METTL14 drives senescence-associated secretory phenotype (SASP) in a m6A-independent manner.  METTL3 and METTL14 are necessary for SASP.  However, SASP is not regulated by m6A mRNA modification.  METTL14 is redistributed to the enhancers, while METTL3 is localized to the pre-existing NF-?B sites within the promoters of the SASP genes during senescence.  METTL3 interacts with NF-?B and they are mutually dependent on their associations with the promoters of SASP genes.  METTL14 but not METTL3 is necessary for function of SASP gene enhancers.  METTL3 and METTL14 are required for both the tumor-promoting and immune surveillance functions of senescent cells mediated by SASP in vivo in mouse models.  In summary, our results report a m6A independent function of the METTL3 and METTL14 complex in promoting SASP through regulating transcription by genome-wide redistribution of METTL14 to enhancers and METTL3 to promoters of SASP genes during senescence. Overall design: carRNA-m6A-seq in control and senescent IMR90 cell lines with and without siMETTL3 and siMETTL14 knockout